Estimating Capacity Utilization in Iranian Pharmaceutical Industry: Pharmaceutical Companies on the Stock Exchange, 2008-2012

Authors

  • Abbas Kebriaei Head of the Center of Economic Research and Drug Management, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran. Pharmaceutical Management and Economics Research Center, Tehran University of Medical Sciences, Iran.
  • Abolghasem Pourreza Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  • Farid dorkoosh Department of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  • Hassan Heydari Department of Economics, Faculty of Economics and Management, Tarbiat Modares University, Tehran, Iran
  • majid annabi Department of Pharmacoeconomics and Pharmaceutical administration, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  • Seyed Nasrolah Shoshtari Department of Industrial Engineering and Management System, Faculty of Industrial Engineering, Amirkabir University of Technology
  • Timor Mohammadi Department of Theoretical Economics, Faculty of Economics, Allameh Tabataba'i University, Tehran, Iran
Abstract:

This study aims to measure the production capacity and capacity utilization in pharmaceutical industry. The capacity utilization is the ratio of actual production level to the potential production level which shows the gap between real production and production capacity. Method: Through econometric methods, the short-run translog cost function is estimated with the cost share function of production factors using iterative seemingly unrelated regression equations (SURE) as a multi-variable regression presented by zeller. Findings: The capacity used during the study years has had a downward trend. The capacity utilization measured by industry weighted average had also a downward trend and its amount has always been much less than the industry simple average during the study years. Industry’s capacity utilization average in five years study is 57% while the average capacity utilization measured by industry weighted average method is 37%. Conclusion: To enhance the economic capacity, the proper use of resources, creating a desirable economic structure and having a system of efficiency in industry are required. In spite of the large amount of unused capacity in pharmaceutical industry, there is no need for further investment except in new fields and it is obvious that increase in investment leads to the changes in capacity utilization.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

An Estimation of the Potential Utilization in Iranian Pharmaceutical Industry Involved in the Stock Exchange, 2008-2012

The aim of this study was to measure the potential of production and the capacity used in the pharmaceutical industry. Capacity use is the actual production rate to the potential output, which reflects the gap between actual production and production capacity. Through econometric methods, translog cost function in the short run along with functions of share cost of production factors is estimat...

full text

Fundamentals and Stock Return in Pharmaceutical Companies: a Panel Data Model of Iranian Industry

Stock return is usually considered to be affected by firm’s financial ratios as well as economic variables. Fundamental method assume that stock returns is not solely related to the stock market. Most result come from the company condition , industry situation and whole economy. In this paper, this relationship between stock return and fundamentals is studied using the data for 22 pharmaceutica...

full text

The Impact of Rational Governance on the Financial Performance of Industrial Companies Sample (Pharmaceutical Companies) Listed in Amman Stock Exchange

The study aimed to determine the impact between rational governance and financial performance on a sample of pharmaceutical companies listed in the Amman Stock Exchange. The questionnaire was used to collect data, where (200) inquiries were received (170) valid for statistical analysis were excluded (10) where used in Analysis process (160) of the total questionnaires distributed and to achieve...

full text

fundamentals and stock return in pharmaceutical companies: a panel data model of iranian industry

stock return is usually considered to be affected by firm’s financial ratios as well as economic variables. fundamental method assume that stock returns is not solely related to the stock market. most result come from the company condition , industry situation and whole economy. in this paper, this relationship between stock return and fundamentals is studied using the data for 22 pharmaceutica...

full text

Perspectives on the pharmaceutical industry.

This paper seeks to provide an economic perspective on the pharmaceutical industry, which has come under increasing criticism on a number of issues. In the main, that criticism amounts to a rather ineffective flailing at the supply side of the market for pharmaceutical products-much of it based on inaccurate perceptions-when a more productive policy would be to strengthen the hitherto weak and ...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 16  issue 4

pages  1648- 1657

publication date 2017-11-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023